These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 32750329)

  • 1. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
    Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway.
    Liu B; Xie H; Du X; Zhou Y; Huang J
    Int Heart J; 2023; 64(5):910-917. PubMed ID: 37778994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress.
    Zhang J; Zha Y; Jiao Y; Li Y; Zhang S
    Toxicology; 2023 Feb; 485():153426. PubMed ID: 36639017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro.
    Wang C; Hu L; Guo S; Yao Q; Liu X; Zhang B; Meng X; Yang X
    Toxicology; 2021 Aug; 460():152881. PubMed ID: 34358621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway.
    Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of
    Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
    Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway.
    He L; Wang J; Yang Y; Zou P; Xia Z; Li J
    Toxicology; 2022 Mar; 469():153119. PubMed ID: 35134463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy.
    Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D
    J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity.
    Pizarro M; Troncoso R; Martínez GJ; Chiong M; Castro PF; Lavandero S
    Toxicology; 2016 Aug; 370():41-48. PubMed ID: 27666003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T; Xiaojun X; Peilong C
    Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.